CELMODS Trademark

Trademark Overview

On Tuesday, June 9, 2015, a trademark application was filed for CELMODS with the United States Patent and Trademark Office. The USPTO has given the CELMODS trademark a serial number of 86656120. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Monday, October 17, 2022. This trademark is owned by Celgene Corporation. The CELMODS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of auto-inflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation
celmods

General Information

Serial Number86656120
Word MarkCELMODS
Filing DateTuesday, June 9, 2015
Status710 - CANCELLED - SECTION 8
Status DateMonday, October 17, 2022
Registration Number4931074
Registration DateTuesday, April 5, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 19, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in the treatment of auto-inflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateMonday, October 17, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCelgene Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events

Event DateEvent Description
Friday, December 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, December 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 9, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, December 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, October 17, 2022CANCELLED SEC. 8 (6-YR)
Monday, April 5, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, April 5, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, January 19, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 19, 2016PUBLISHED FOR OPPOSITION
Wednesday, December 30, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, December 14, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, December 4, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 5, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 5, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 5, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 6, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 28, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 27, 2015ASSIGNED TO LIE
Tuesday, October 6, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 29, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 29, 2015NON-FINAL ACTION E-MAILED
Tuesday, September 29, 2015NON-FINAL ACTION WRITTEN
Friday, September 18, 2015ASSIGNED TO EXAMINER
Tuesday, July 28, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 12, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, June 12, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

celmods disease diseases musculoskeletal skin fields inflammation immunology oncology arthritis cancer